Amphastar Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

Date: March 11, 2014
Pages: 15
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Company Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Amphastar Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Amphastar Pharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.

Amphastar Pharmaceuticals, Inc. (Amphastar) is a specialty and generic pharmaceutical company which focuses on the development, manufacturing and marketing of proprietary and generic injectable and inhalation products. Amphastar’s products include enoxaparin sodium injection; cosyntropin for injection; morphine Sulfate Injection, USP; Lidocaine HCl Jelly, USP 2%; phytonadione injection; epinephrine Injection; naloxone HCl injection; Lidocaine HCl, 4% Topical Solution; and phytonadione injection. The company manufactures and sells 15 products.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Amphastar Pharmaceuticals, Inc. - Key Facts
Amphastar Pharmaceuticals, Inc. - Key Employees
Amphastar Pharmaceuticals, Inc. - Key Employee Biographies
Amphastar Pharmaceuticals, Inc. - Major Products and Services
Amphastar Pharmaceuticals, Inc. - History
Amphastar Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries


Amphastar Pharmaceuticals, Inc. - Business Description
Amphastar Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
Amphastar Pharmaceuticals, Inc. - Strengths
Strength - Broad Product Portfolio
Strength - Focused Research and Development Activities
Strength - Integrated Facilities
Amphastar Pharmaceuticals, Inc. - Weaknesses
Weakness - Involvement in Legal Proceeding
Weakness - Lack of Transparency in Operations
Amphastar Pharmaceuticals, Inc. - Opportunities
Opportunity - Growth Prospects: Generics Market
Opportunity - Demographic Trends
Opportunity - Rising Healthcare Expenditure in the US
Amphastar Pharmaceuticals, Inc. - Threats
Threat - Competitive Pressures
Threat - Industry Regulations
Threat - Uncertain R&D Outcomes
Amphastar Pharmaceuticals, Inc. - Key Competitors


About GlobalData
Contact Us


Amphastar Pharmaceuticals, Inc., Key Facts
Amphastar Pharmaceuticals, Inc., Key Employees
Amphastar Pharmaceuticals, Inc., Key Employee Biographies
Amphastar Pharmaceuticals, Inc., Major Products and Services
Amphastar Pharmaceuticals, Inc., History
Amphastar Pharmaceuticals, Inc., Subsidiaries
Amphastar Pharmaceuticals, Inc., Key Competitors
Skip to top

Ask Your Question

Amphastar Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: